Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity.

Journal of clinical pathology - 1 Jan 2012

Lin Francini de Mattos Lima, Pincerato Katia Maciel, Bacchi Carlos Eduardo, Baracat Edmund Chada, Carvalho Filomena Marino

Abstract excerpt

AIMS: Human epidermal growth factor receptor 2 (HER2)-positive breast cancers are aggressive neoplasms associated with a variable response to systemic therapies. Therefore, the identification of biomarkers to better characterise this heterogeneity would improve treatment efficacy. The aim of this study was to evaluate the influence of androgen receptor (AR) and oestrogen receptor (ER) on clinicopathological...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to Chi-Square Distribution

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ki-67 Antigen

Share to Receptor, ErbB-2

Share to Receptors, Androgen

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Share to Tissue Array Analysis

Source

Identifiers

PMID: 22039288
DOI: 10.1136/jclinpath-2011-200318

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity.PMID 22039288Read ↗

AR/ER Ratio Correlates with Expression of Proliferation Markers and with Distinct Subset of Breast TumorsSemantic proximity Read ↗

Androgen receptor expression in breast cancer patients tested for BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Triple positive breast cancer: a distinct subtype?Semantic proximity Read ↗

Relationship between androgen receptor and androgen receptor-related protein expression in breast cancers focusing on morphologically identified carcinoma with apocrine differentiationSemantic proximity Read ↗

Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers.Semantic proximity Read ↗

Profiling of Estrogen Up- and Down-Regulated Gene Expression in Human Breast Cancer Cells: Insights into Gene Networks and Pathways Underlying Estrogenic Control of Proliferation and Cell PhenotypeSemantic proximity Read ↗

EGFR and HER-2/neu expression in invasive apocrine carcinoma of the breast.Semantic proximity Read ↗

HER2-positive Apocrine Carcinoma of the Breast: A population-based Analysis of Treatment and OutcomeSemantic proximity Read ↗

Breast cancer molecular class ERBB2: preponderance of tumors with apocrine differentiation and expression of basal phenotype markers CK5, CK5/6, and EGFR.Semantic proximity Read ↗

A Feedback Loop between Androgen Receptor and ERK Signaling in Estrogen Receptor-Negative Breast CancerSemantic proximity Read ↗

Factors predictive of response to hormone therapy in breast cancer.Semantic proximity Read ↗

Relationships between progesterone receptor isoforms and the HER/ErbB receptors and ligands network in 299 primary breast cancersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.